PANACOS PHARMACEUTICALS INC. PANC (NASDAQd) $ 0.17 Change: -0.01 -5.88% | Volume: 71,603
Sponsored by Click here!

PANACOS PHARMA - Fundamental Profile

Company Information

Ticker Symbol: PANC
Exchange: NASD
Contact Info: 134 Coolidge Avenue Watertown MA 02472 617-926-1551
CEO/President: Alan W. Dunton M.D
Industry: Medical - Biomedical / Standard Industry Code: 2836
Description: Panacos is developing the next generation of anti-infective products through discovery and development of small molecule oral drugs for the treatment of HIV and other major human viral diseases. Panacos\' proprietary discovery technologies and lead therapeutic candidate PA-457 focus on novel targets in the virus life cycle, including virus fusion and virus maturation.

Share Information

Shares Outstanding: 53,640 (000) Market Value: 10,460 ($000)
Percentage of Inst.Shareholders: 44.80% Number of Inst.Shareholders: 6.90%
Last Quarter Sales: 0.02 ($Mil.) Last Quarter Net Income: -8.15 ($Mil.)
Last Quarter EPS: -0.15 P/E Ratio: 0
Most Recent Earnings: Earnings Per Share: -0.66
Most Recent Split: Annual Dividend Rate: 0
Most Recent Dividend: Annual Dividend Yield: 0%
Data Provided By Barchart.com
CoreData does not represent, warrant, or guarantee completeness, accuracy or timeliness of its data, and shall have no liability of any kind whatsoever to any party on account of any incompleteness of, inaccuracies in or untimeliness of the CoreData content provided hereunder, or for any delay in reporting such data. CoreData expressly disclaims all warranties of fitness of the CoreData content or computations and analyses thereof for a particular purpose or use.
advertisement